Clinical trial
A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in…
NCT00239382 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00239382 |
|---|---|
| Title | A Study to Compare Meloxicam IM Once Daily Versus Meloxicam Orally Once Daily in Patients With Rheumatoid Arthritis |
| Official title | A Randomized, Open-labelled Study to Compare the Efficacy and Safety of Meloxicam 15 mg IM Ampoules Once Daily and Meloxicam 15 mg Tablets Administered Orally Once Daily Over a Period of 7 Days in Patients With RA. |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | Meloxicam ampoule, Meloxicam tablet |
| Enrollment | 150 |
| Start date | Jul 1, 2004 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 31, 2004 |
| First posted | Oct 17, 2005 |
| Last update posted | Aug 3, 2018 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: